Effects of Hyperforin on the Fluidity of Brain Membranes

Hyperforin, an acylphloroglucinol derivative isolated from Hypericum perforatum (St. John's wort, SJW), affects several ionic conductance mechanisms in brain cells by an as yet unknown mechanism. We tested the effects of hyperforin on the fluidity of crude brain membranes from young guinea pigs. We performed fluidity measurements with three different fluorescent probes. Diphenylhexatriene (DPH) and trimethylammonium-diphenylhexatriene (TMA-DPH) anisotropy measurements were inversely correlated with the flexibility of fatty acids in the membrane hydrocarbon core and in the hydrophilic area of membrane phospholipids, respectively. The ratio of pyrene excimer to monomer fluorescence intensities was used as an indicator of membrane annular and bulk fluidity. Incubation of brain membranes with relatively high concentrations of hyperforin sodium salt (10 µmol/l) resulted in increased DPH and decreased TMA-DPH anisotropy, respectively, indicating that hyperforin modifies specific membrane structures in different ways. It decreases the flexibility of fatty acids in the membrane hydrocarbon core, but fluidizes the hydrophilic region of membrane phospholipids. Interestingly, relatively low concentrations of hyperforin (0.3 µmol/l) significantly decreased the annular fluidity of lipids close to membrane proteins. These findings are remarkable, as inhibition of several neurotransmitter-uptake systems and modulation of several ionic conductance mechanisms by hyperforin occur in the same concentration range. However, bulk fluidity was unchanged by this low hyperforin concentration. The results emphasise a physicochemical interaction of hyperforin with specific membrane structures that probably contribute to its novel pharmacological properties.

References

• 1 Avdulov N A, Chochina S V, Igbavboa U, O'Hare E O, Schroeder F, Cleary J P, Wood W G. Amyloid beta-peptides increase annular and bulk fluidity and induce lipid peroxidation in brain synaptic plasma membranes.  J Neurochem. 1997;  68 2086-2091
• 2 Brenneman D E, Rutledge C O. Alteration of catecholamine uptake in cerebral cortex from rats fed a saturated fat diet.  Brain Res. 1979;  179 295-304
• 3 Carr P, Taub N A, Watts G F, Poston L. Human lymphocyte sodium-hydrogen exchange. The influences of lipids, membrane fluidity, and insulin.  Hypertension. 1993;  21 344-352
• 4 Chatterjee S S, Bhattacharya S K, Wonnemann M, Singer A, Muller W E. Hyperforin as a possible antidepressant component of Hypericum extracts.  Life Sci. 1998;  63 499-510
• 5 Chatterjee S, Filippov V, Lishko P, Maximyuk O, Noldner M, Krishtal O. Hyperforin attenuates various ionic conductance mechanisms in the isolated hippocampal neurons of rat.  Life Sci. 1999;  65 2395-2405
• 6 Clarke M S, Prendergast M A, Terry A VJ. Plasma membrane ordering agent pluronic F-68 (PF-68) reduces neurotransmitter uptake and release and produces learning and memory deficits in rats.  Learn Mem. 1999;  6 634-649
• 7 Fisunov A, Lozovaya N, Tsintsadze T, Chatterjee S, Noldner M, Krishtal O. Hyperforin modulates gating of P-type Ca2+ current in cerebellar Purkinje neurons.  Pflugers Arch. 2000;  440 427-434
• 8 Gobbi M, Valle F D, Ciapparelli C, Diomede L, Morazzoni P, Verotta L, Caccia S, Cervo L, Mennini T. Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex.  Naunyn Schmiedebergs Arch Pharmacol. 1999;  360 262-269
• 9 Harris R A, Bruno P. Membrane disordering by anesthetic drugs: relationship to synaptosomal sodium and calcium fluxes.  J Neurochem. 1985;  44 1274-1281
• 10 Kaehler S T, Sinner C, Chatterjee S S, Philippu A. Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus.  Neurosci Lett. 1999;  262 199-202
• 11 Kaiser R D, London E. Location of diphenylhexatriene (DPH) and its derivatives within membranes: comparison of different fluorescence quenching analyses of membrane depth.  Biochemistry. 1998;  37 8180-8190
• 12 Kutscherskij E, Gunther J, Mehley E. K-p-nitrophenylphosphatase activity, Na and K content, Na permeability and membrane lipid composition in rabbit myocardium after cholesterol rich diet.  Experientia. 1984;  40 812-815
• 13 Laakmann G, Schule C, Baghai T, Kieser M. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.  Pharmacopsychiatry. 1998;  31 (Suppl. 1:45 - 9) 54-59
• 14 Lehotsky J, Kaplan P, Racay P, Matejovicova M, Drgova A, Mezesova V. Membrane ion transport systems during oxidative stress in rodent brain: protective effect of stobadine and other antioxidants.  Life Sci. 1999;  65 1951-1958
• 15 Linde K, Ramirez G, Mulrow C D, Pauls A, Weidenhammer W, Melchart D. St. John's wort for depression - an overview and meta-analysis of randomised clinical trials.  BMJ. 1996;  313 253-258
• 16 Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the folin phenol reagent.  J Biol Chem. 1951;  193 265-275
• 17 McCall D, Henderson G I, Gray P, Schenker S. Ethanol effects on active Na⁺ and K⁺ transport in cultured fetal rat hepatocytes.  Biochem Pharmacol. 1989;  38 2593-2600
• 18 Müller W E, Singer A, Wonnemann M, Hafner U, Rolli M, Schafer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract.  Pharmacopsychiatry. 1998;  31 (Suppl. 1) 6-21
• 19 Nahrstedt A, Butterweck V. Biologically active and other chemical constituents of the herb of Hypericum perforatum L.  Pharmacopsychiatry. 1997;  30 (Suppl. 2) 129-134
• 20 North P E, Mrak R E. Synaptosomal uptake of choline and of gamma-aminobutyric acid: effects of ethanol and of dimethylsulfoxide.  Neurotoxicology. 1989;  10 569-576
• 21 Shinitzky M, Barenholz Y. Fluidity parameters of lipid regions determined by fluorescence polarization.  Biochim Biophys Acta. 1978;  515 367-394
• 22 Singer A, Wonnemann M, Muller W E. Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na⁺.  J Pharmacol Exp Ther. 1999;  290 1363-1368
• 23 Volz H P. Controlled clinical trials of Hypericum extracts in depressed patients - an overview.  Pharmacopsychiatry. 1997;  30 (Suppl. 2) 72-76
• 24 Wonnemann M, Singer A, Muller W E. Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways.  Neuropsychopharmacology. 2000;  23 188-197
• 25 Zicha J, Kunes J, Le Quan Sang K H, Devynck M A. Regulation of the dynamic properties of platelet plasma membrane by intracellular sodium ions.  Life Sci. 1993;  52 1559-1565